🟢 Immunitybio is trading 4.03% up today with no clear company-specific catalyst

Immunitybio is trading 4.03% up at $7.88, with no clear company-specific catalyst identified for August 17, 2026.

• Its investor-relations page lists the latest releases as the August 10 vice-chairman appointment and August 4 quarterly results.
• No August 17 announcement is listed.
• Broader markets are mixed and lack a major macro catalyst, leaving the move’s explanation uncertain.